The role of metabolic reprogramming in liver cancer and its clinical perspectives

Primary liver cancer (PLC), which includes hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA), remains a leading cause of cancer-related death worldwide. Chronic liver diseases, such as hepatitis B and C infections and metabolic dysfunction-associated steatotic liver disease (...

Full description

Saved in:
Bibliographic Details
Main Authors: Mengxiao Lu, Yingjie Wu, MinMing Xia, Yixin Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-11-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1454161/full
Tags: Add Tag
No Tags, Be the first to tag this record!